Yi, R., Lin, A., Cao, M., Xu, A., Luo, P., & Zhang, J. (2020). ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment. Frontiers Media S.A.
Chicago Style (17th ed.) CitationYi, Ruibin, Anqi Lin, Manming Cao, Abai Xu, Peng Luo, and Jian Zhang. ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment. Frontiers Media S.A, 2020.
MLA (8th ed.) CitationYi, Ruibin, et al. ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment. Frontiers Media S.A, 2020.
Warning: These citations may not always be 100% accurate.